Skip to content

New HCV NS5A inhibitor EDP-239 looks good in early studies, more evidence supports early hepatitis C treatment

Sexual transmission of HCV is increasing among gay and bisexual men with HIV, meta-analysis finds

Cost of comprehensive global viral hepatitis prevention and treatment effort might peak at $11 billion in 2025

Medicines Patent Pool looks at hepatitis C

World Health Organization calls for ambitious global targets for viral hepatitis control

Fatty liver may contribute to higher risk of death for HIV/HCV co-infected people

HCV infection associated with hardening of the coronary artery

People with HIV and hepatitis B co-infection can safely switch to simpler TAF single-tablet regimen

Hepatitis C cure associated with significant improvement in liver stiffness in people with HIV and HCV co-infection